The event is an ideal opportunity to learn about, evaluate and apply novel approaches to streamlining the transition from preclinical research to clinical development and reducing attrition rates early on in the development process of your drug.

The meeting will be held on the 31st and 1st of January in London and features an unrivalled faculty of industry experts including:

- Dr Nigel McCracken, Senior Director, Simulation and Modelling, Altana Pharma
- Dr Ewould van Hoogdalem, Director, Experimental Medicine, Johnson & Johnson
- Dr Lutz Mueller, R&D Project Leader, Non-Clinical Drug Safety, F. Hoffmann-La Roche AG
- Eugenii Rabiner, Clinical Imaging Applications, Translational Medicine and Genetics

Visit the event website at http://www.iir-events.com/IIR-Conf/page.aspx?id=688 to download a brochure for this meeting and book your place now.

There are also still places available at our popular pre-conference workshop:

Developing a Pre-clinical/Clinical Study Plan: from the Design of Pre-clinical Studies to Clinical Development
This workshop gives you the opportunity to discuss the ins and outs of developing a preclinical/clinical study plan and be fully prepared for the conference.

Led by Dr. Sunil Kadam and Dr. Eric Powell at Eli Lilly and Company, Indianapolis, Indiana